TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
BioRent Skandinavien AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
4,046
|
2,831
|
2,370 |
Financial expenses |
24
|
8
|
0 |
Earnings before taxes |
-3
|
74
|
72 |
EBITDA |
101
|
126
|
68 |
Total assets |
1,190
|
833
|
628 |
Current assets |
920
|
654
|
628 |
Current liabilities |
824
|
529
|
499 |
Equity capital |
170
|
169
|
124 |
- share capital |
51
|
47
|
49 |
Employees (average) |
6
|
5
|
3 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
14.3%
|
20.3%
|
19.7% |
Turnover per employee |
674
|
566
|
790 |
Profit as a percentage of turnover |
-0.1%
|
2.6%
|
3.0% |
Return on assets (ROA) |
1.8%
|
9.8%
|
11.5% |
Current ratio |
111.7%
|
123.6%
|
125.9% |
Return on equity (ROE) |
-1.8%
|
43.8%
|
58.1% |
Change turnover |
1,014
|
533
|
918 |
Change turnover % |
33%
|
23%
|
63% |
Chg. No. of employees |
1
|
2
|
-3 |
Chg. No. of employees % |
20%
|
67%
|
-50% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.